Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone

• Mwanza Intervention Trials Unit (TZ)
• National Institute for Medical Research (TZ)

tal como impresso: I Kamara

• University of Sierra Leone (SL)

tal como impresso: AT Deen

• Mwanza Intervention Trials Unit (TZ)
• National Institute for Medical Research (TZ)

tal como impresso: AH Koroma

• Institut de Recherche Agronomique de Guinée (GN)

tal como impresso: AB Jalloh

tal como impresso: A Sow

• University of Sierra Leone (SL)

• Mwanza Intervention Trials Unit (TZ)
• National Institute for Medical Research (TZ)

• Mwanza Intervention Trials Unit (TZ)
• National Institute for Medical Research (TZ)

tal como impresso: J-HC Sunders

• Mwanza Intervention Trials Unit (TZ)
• National Institute for Medical Research (TZ)

• Cheikh Anta Diop University (SN)

• Mwanza Intervention Trials Unit (TZ)
• National Institute for Medical Research (TZ)

tal como impresso: T Sesay

• Mwanza Intervention Trials Unit (TZ)
• National Institute for Medical Research (TZ)

tal como impresso: S Lees

• Mwanza Intervention Trials Unit (TZ)
• National Institute for Medical Research (TZ)

tal como impresso: H Larson

• Mwanza Intervention Trials Unit (TZ)
• National Institute for Medical Research (TZ)

tal como impresso: F Faye

tal como impresso: D Tindanbil

• University of Sierra Leone (SL)

tal como impresso: FE Morovia

tal como impresso: JA Kallon